Yu-Chen Su is a seasoned biostatistics professional currently serving as the Director of Biostatistics & Programming at Stryker since April 2025, following the acquisition of Inari Medical. Prior to this role, Yu-Chen held the Director position at Inari Medical, leading efforts in the venous thromboembolism field and emphasizing a player-coach mentality within the Biostatistics and Programming team. Yu-Chen's previous experience includes significant roles at Biogen, Edwards Lifesciences, Takeda Pharmaceuticals, and Neural Analytics, with notable contributions in real-world evidence, statistical analysis, and machine learning applications across various therapeutic areas. Holding a PhD in Biostatistics/Statistical Genetics from the University of Southern California, along with additional degrees in Biostatistics and Biomedical Engineering, Yu-Chen has a strong academic background that complements extensive industry experience.
This person is not in the org chart
This person is not in any teams
This person is not in any offices